Trial Profile
Effects of switching from ramipril to sacubitril/valsartan on electrocardiographic indices of ventricular repolarization in heart failure with reduced ejection fraction.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Dec 2018
Price :
$35
*
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 18 Dec 2018 New trial record
- 04 Dec 2018 Results published in the Acta Cardiologica